Arthritis, Musculoskeletal and Skin Diseases Research in South Carolina
Arthritis, Musculoskeletal and Skin Diseases Research (93.846) awarded $20.2 million to recipients in South Carolina in 27 grants from fiscal 2021 to 2025, 0.8% of the program's national total. The Medical University of South Carolina received the most, $14.5 million.
- Awarded in South Carolina$20.2 million
- Awards27
- Share of the program0.8%
- Rank among states27th of 44
- National total$2.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 11 | $3.9 million |
| FY 2022 | 13 | $4.8 million |
| FY 2023 | 13 | $4.0 million |
| FY 2024 | 12 | $4.2 million |
| FY 2025 | 10 | $3.1 million |
Recipients in South Carolina
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Medical University of South Carolina | Colleges and universities | 15 | $14.5 million |
| Apex Orthopaedic Technologies LLC | Small businesses | 2 | $2.4 million |
| University of South Carolina | Colleges and universities | 3 | $1.3 million |
| Aravis Biotech LLC | Small businesses | 2 | $599,998 |
| Fibrobiologics LLC | Small businesses | 2 | $558,528 |
| Zylo Therapeutics, Inc. | Small businesses | 1 | $293,749 |
| Fibrotherapeutics Inc | Small businesses | 1 | $259,601 |
| Tissue Testing Technologies LLC | Small businesses | 1 | $210,219 |
Open opportunities under this program
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
See all 60 on the program page
Questions people ask
How much Arthritis, Musculoskeletal and Skin Diseases Research money goes to South Carolina?
$20.2 million from fiscal 2021 to 2025, across 27 awards. South Carolina ranks 27th of 44 states and territories for this program.
Who receives Arthritis, Musculoskeletal and Skin Diseases Research money in South Carolina?
The largest recipient is The Medical University of South Carolina, with $14.5 million in 15 awards. Next are Apex Orthopaedic Technologies LLC and University of South Carolina.
Can organizations in South Carolina apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Arthritis, Musculoskeletal and Skin Diseases Research in other states
Other large programs in South Carolina
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Head Start